Zephrex D Capsule, Gelatin Coated
NDC Package 0113-0401-67
Package Information
Zephrex D (pseudoephedrine hydrochloride) capsules is adults and children 12 years and over•take 2 softgels every 4 to 6 hours•do not take more than 8 softgels in 24 hourschildren ages 6 to under 12 years•take 1 softgel every 4 to 6 hours•do not take more than 4 softgels in 24 hourschildren under 6 yearsdo not use this product in children under 6 years of age. This formulation utilizes a capsule, gelatin coated delivery system. Marketed by L. Perrigo Company, this product is identified by NDC 0113-0401 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1430169 - pseudoephedrine HCl 30 MG Oral Capsule
- RxCUI: 1430169 - pseudoephedrine hydrochloride 30 MG Oral Capsule
- RxCUI: 1918218 - Zephrex-D 30 MG Oral Capsule
- RxCUI: 1918218 - pseudoephedrine hydrochloride 30 MG Oral Capsule [Zephrex-D]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0113 - L. Perrigo Company
- 0113-0401 - Zephrex D
- 0113-0401-67 - 48 BLISTER PACK in 1 CARTON / 1 CAPSULE, GELATIN COATED in 1 BLISTER PACK
- 0113-0401 - Zephrex D
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0113-0401). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0113-0401-67 identifies a specific commercial package of 48 blister pack in 1 carton / 1 capsule, gelatin coated in 1 blister pack of Zephrex D, a human over the counter drug labeled by L. Perrigo Company. This capsule, gelatin coated is formulated for oral use and contains pseudoephedrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by L. Perrigo Company on November 04, 2016. The current certification is valid through December 31, 2026.
How is this L. Perrigo Company product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00113040167. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.